Glory Health Industry Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Glory Health Industry han disminuido a una tasa media anual de -65.2%, mientras que en la industria Real Estate los beneficios crecieron en un 3.8% anualmente. Los ingresos han ido disminuyendo a una tasa media de 23% al año.

Información clave

-65.2%

Tasa de crecimiento de los beneficios

-65.2%

Tasa de crecimiento del BPA

Crecimiento de la industria Real Estate	-2.1%
Tasa de crecimiento de los ingresos	-23.0%
Rentabilidad financiera	-2.8%
Margen neto	-17.5%
Última actualización de beneficios	30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Glory Health Industry. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

DB:84R Ingresos, gastos y beneficios (CNY Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	2,037	-356	371
31 Mar 24	2,272	-460	403
31 Dec 23	2,506	-564	434
30 Sep 23	2,461	-531	463
30 Jun 23	2,415	-497	492
31 Mar 23	3,160	-705	510
31 Dec 22	3,905	-913	529
30 Sep 22	5,087	-817	645
30 Jun 22	6,270	-721	761
31 Mar 22	8,084	-246	756
31 Dec 21	9,898	228	751
30 Sep 21	9,460	261	704
30 Jun 21	9,021	294	657
31 Mar 21	7,395	196	699
31 Dec 20	5,769	99	741
30 Sep 20	6,705	301	775
30 Jun 20	7,641	502	808
31 Mar 20	7,867	681	836
31 Dec 19	8,093	860	863
30 Sep 19	8,121	943	859
30 Jun 19	8,149	1,027	854
31 Mar 19	7,381	1,018	784
31 Dec 18	6,612	1,009	715
30 Sep 18	6,728	1,335	641
30 Jun 18	6,844	1,662	567
31 Mar 18	6,816	1,706	561
31 Dec 17	6,787	1,750	556
30 Sep 17	6,674	1,474	578
30 Jun 17	6,561	1,198	600
31 Mar 17	7,298	1,380	595
31 Dec 16	8,035	1,563	590
30 Sep 16	7,807	1,457	591
30 Jun 16	7,580	1,351	592
31 Mar 16	7,047	1,306	598
31 Dec 15	6,514	1,261	605
30 Sep 15	6,060	1,380	563
30 Jun 15	5,606	1,500	521
31 Mar 15	5,442	1,225	488
31 Dec 14	5,279	951	455
30 Sep 14	5,688	896	455
30 Jun 14	6,097	841	455
31 Mar 14	6,466	1,537	441
31 Dec 13	6,835	2,234	427

Ingresos de calidad: 84R actualmente no es rentable.

Margen de beneficios creciente: 84R actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 84R no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 65.2% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de 84R en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: 84R no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Real Estate (6.6%).

Rentabilidad financiera

Alta ROE: 84R tiene una rentabilidad financiera negativa (-2.83%), ya que actualmente no es rentable.

Glory Health Industry Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Recent updates

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 59% undervalued after recent price drop

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought €171k worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado